“Stephanie Lodise offers impressive experience in advising pharmaceutical companies on patent portfolio management and development.”
— Chambers USA 2023
Stephanie Lodise is co-leader of the firm’s Biotechnology, Chemical and Pharmaceutical Team and a patent attorney with more than 18 years of experience in securing, expanding and maintaining exclusivity for pharmaceuticals in the U.S. and abroad. She focuses on building patent portfolios for both new and re-purposed small molecules, reinforcing mature patent portfolios, analyzing freedom-to-market issues, managing patent office administrative impediments, navigating patent landscapes and developing patent protection for products subject to Hatch-Waxman litigation.
Areas of Focus
New York Court of Appeals Confirms Attorney-Client Privilege Can Apply Without Anticipated/Pending Litigation or Client’s Affirmative Request for Legal Advice
02/23/2024|2 minute read
No Further Warnings – Prosecutors Bring First Pure Legal Digital Asset Tax Indictment; More Criminal Cases to Come
02/23/2024|3 minute read